Elevated expression of miR-494-3p is associated with resistance to osimertinib in EGFR T790M-positive non-small cell lung cancer - Concepedia

Concepedia

Publication | Open Access

Elevated expression of miR-494-3p is associated with resistance to osimertinib in EGFR T790M-positive non-small cell lung cancer

DOI Full Paper Access

19

Citations

42

References

2022

Year

Dominika Kaźmierczak, Inger Johanne Zwicky Eide, Radosveta Gencheva, Yi Chun Lai, Rolf Lewensohn, Georgios Tsakonas, Oscar Grundberg, Luigi De Petris, Marc McGowan, Odd Terje Brustugun,

Translational Lung Cancer Research

Abstract

Our results highlight the need for further therapeutic exploration of miR-494-3p in <i>in vivo</i> models of <i>EGFR</i>-mutant NSCLC.

References

	Year	Citations
MicroRNA expression profiles classify human cancers Jun Lü, Gad Getz, Eric A. Miska, Nature PathologyCancer GenomicsMicrorna Expression ProfilesMicrorna DetectionMedicine	2005	9.5K
<i>EGFR</i> Mutation and Resistance of Non–Small-Cell Lung Cancer to Gefitinib Susumu Kobayashi, Titus J. Boggon, Tajhal Dayaram, New England Journal of Medicine	2005	3.9K
Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated with a Second Mutation in the EGFR Kinase Domain William Pao, Vincent A. Miller, Katerina Politi, PLoS Medicine	2005	3.5K
Overall Survival with Osimertinib in Untreated, <i>EGFR</i> -Mutated Advanced NSCLC Suresh S. Ramalingam, Johan Vansteenkiste, David Planchard, New England Journal of Medicine	2019	2.7K
AZD9291 in EGFR Inhibitor–Resistant Non–Small-Cell Lung Cancer Pasi A. Jänne, James Chih‐Hsin Yang, Dong‐Wan Kim, New England Journal of Medicine	2015	2.1K
Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials James Chih‐Hsin Yang, Yi‐Long Wu, Martin Schüler, The Lancet Oncology Lux-lung 3Lux-lung 6MedicinePathologyBronchial Neoplasm	2015	1.6K
A Prospective, Molecular Epidemiology Study of EGFR Mutations in Asian Patients with Advanced Non–Small-Cell Lung Cancer of Adenocarcinoma Histology (PIONEER) Yuankai Shi, Joseph S. K. Au, Sumitra Thongprasert, Journal of Thoracic Oncology	2014	1.5K
Inherited susceptibility to lung cancer may be associated with the T790M drug resistance mutation in EGFR Daphne W. Bell, Ira Gore, Ross A. Okimoto, Nature Genetics Tumor BiologySomatic VariantMedicineGeneticsPathology	2005	528
MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers Masahiro Seike, Akiteru Goto, Tetsuya Okano, Proceedings of the National Academy of Sciences EngineeringPathologyTumor BiologyLung Cancer CasesMolecular Diagnostics	2009	498
Characterization of RNA from Exosomes and Other Extracellular Vesicles Isolated by a Novel Spin Column-Based Method Daniel Enderle, Alexandra Spiel, Christine M. Coticchia, PLoS ONE Spin ColumnsEngineeringNatural SciencesRna Structure PredictionRna Biology	2015	385

Page 1